Paul J Clancy - Net Worth and Insider Trading
Paul J Clancy Net Worth
The estimated net worth of Paul J Clancy is at least $19 Million dollars as of 2024-04-23. Paul J Clancy is the EVP, CFO of Alexion Pharmaceuticals Inc and owns about 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $17 Million. Paul J Clancy is also the Executive VP and CFO of Biogen Inc and owns about 10,813 shares of Biogen Inc (BIIB) stock worth over $2 Million. Details can be seen in Paul J Clancy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul J Clancy has not made any transactions after 2018-07-10 and currently still holds the listed stock(s).
Transaction Summary of Paul J Clancy
Paul J Clancy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul J Clancy owns 6 companies in total, including Incyte Corp (INCY) , Agios Pharmaceuticals Inc (AGIO) , and Alexion Pharmaceuticals Inc (ALXN) among others .
Click here to see the complete history of Paul J Clancy’s form 4 insider trades.
Insider Ownership Summary of Paul J Clancy
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INCY | Incyte Corp | 2023-09-29 | director |
AGIO | Agios Pharmaceuticals Inc | 2013-09-24 | director |
ALXN | Alexion Pharmaceuticals Inc | 2019-07-11 | EVP & Chief Financial Officer |
BIIB | Biogen Inc | 2017-04-25 | Executive VP and CFO |
EXAS | Exact Sciences Corp | 2021-03-18 | director |
XLO | Xilio Therapeutics Inc | 2021-10-21 | director |
Paul J Clancy Latest Holdings Summary
Paul J Clancy currently owns a total of 2 stocks. Among these stocks, Paul J Clancy owns 93,309 shares of Alexion Pharmaceuticals Inc (ALXN) as of July 10, 2018, with a value of $17 Million and a weighting of 89.07%. Paul J Clancy also owns 10,813 shares of Biogen Inc (BIIB) as of April 25, 2017, with a value of $2 Million and a weighting of 10.93%.
Latest Holdings of Paul J Clancy
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2018-07-10 | 93,309 | 182.50 | 17,028,893 |
BIIB | Biogen Inc | 2017-04-25 | 10,813 | 193.18 | 2,088,855 |
Holding Weightings of Paul J Clancy
Paul J Clancy Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,241 shares on July 10, 2018, which brought Paul J Clancy around $687,148.
According to the SEC Form 4 filings, Paul J Clancy has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,892 shares on April 25, 2017, which brought Paul J Clancy around $3 Million.
Insider Trading History of Paul J Clancy
- 1
Paul J Clancy Trading Performance
Paul J Clancy Ownership Network
Ownership Network List of Paul J Clancy
Ownership Network Relation of Paul J Clancy
Paul J Clancy Owned Company Details
What does Incyte Corp do?
Who are the key executives at Incyte Corp?
Paul J Clancy is the director of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Paul J Clancy made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .
In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
Paul J Clancy Mailing Address
Above is the net worth, insider trading, and ownership report for Paul J Clancy. You might contact Paul J Clancy via mailing address: C/o Biogen Idec Inc., 14 Cambridge Center, Cambridge Ma 02142.